Structural basis of regulated m


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
01 2023
Historique:
received: 22 05 2022
accepted: 16 11 2022
pubmed: 5 1 2023
medline: 14 1 2023
entrez: 4 1 2023
Statut: ppublish

Résumé

Chemical modifications of RNA have key roles in many biological processes

Identifiants

pubmed: 36599985
doi: 10.1038/s41586-022-05566-4
pii: 10.1038/s41586-022-05566-4
doi:

Substances chimiques

GTP-Binding Proteins EC 3.6.1.-
Methyltransferases EC 2.1.1.-
METTL1 protein, human EC 2.1.1.-
RNA, Transfer 9014-25-9
WDR4 protein, human 0
7-methylguanosine 2140-77-4

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

391-397

Subventions

Organisme : NCI NIH HHS
ID : HHSN261200800001E
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA214608
Pays : United States
Organisme : NCI NIH HHS
ID : R35 CA232115
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA218278
Pays : United States

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer Nature Limited.

Références

Roundtree, I. A., Evans, M. E., Pan, T. & He, C. Dynamic RNA modifications in gene expression regulation. Cell 169, 1187–1200 (2017).
pubmed: 28622506 pmcid: 5657247 doi: 10.1016/j.cell.2017.05.045
Frye, M., Harada, B. T., Behm, M. & He, C. RNA modifications modulate gene expression during development. Science 361, 1346–1349 (2018).
pubmed: 30262497 pmcid: 6436390 doi: 10.1126/science.aau1646
Barbieri, I. & Kouzarides, T. Role of RNA modifications in cancer. Nat. Rev. Cancer 20, 303–322 (2020).
pubmed: 32300195 doi: 10.1038/s41568-020-0253-2
Motorin, Y. & Helm, M. tRNA stabilization by modified nucleotides. Biochemistry 49, 4934–4944 (2010).
pubmed: 20459084 doi: 10.1021/bi100408z
Tomikawa, C. 7-Methylguanosine modifications in transfer RNA (tRNA). Int. J. Mol. Sci. 19, 4080 (2018).
pubmed: 30562954 pmcid: 6320965 doi: 10.3390/ijms19124080
Alexandrov, A. et al. Rapid tRNA decay can result from lack of nonessential modifications. Mol. Cell 21, 87–96 (2006).
pubmed: 16387656 doi: 10.1016/j.molcel.2005.10.036
Whipple, J. M., Lane, E. A., Chernyakov, I., D’Silva, S. & Phizicky, E. M. The yeast rapid tRNA decay pathway primarily monitors the structural integrity of the acceptor and T-stems of mature tRNA. Genes Dev. 25, 1173–1184 (2011).
pubmed: 21632824 pmcid: 3110955 doi: 10.1101/gad.2050711
Alexandrov, A., Martzen, M. R. & Phizicky, E. M. Two proteins that form a complex are required for 7-methylguanosine modification of yeast tRNA. RNA 8, 1253–1266 (2002).
pubmed: 12403464 pmcid: 1370335 doi: 10.1017/S1355838202024019
Leulliot, N. et al. Structure of the yeast tRNA m7G methylation complex. Structure 16, 52–61 (2008).
pubmed: 18184583 doi: 10.1016/j.str.2007.10.025
Orellana, E. A. et al. METTL1-mediated m
pubmed: 34352207 pmcid: 8380730 doi: 10.1016/j.molcel.2021.06.031
Dai, Z. et al. N
pubmed: 34352206 doi: 10.1016/j.molcel.2021.07.003
Ma, J. et al. METTL1/WDR4-mediated m7G tRNA modifications and m7G codon usage promote mRNA translation and lung cancer progression. Mol. Ther. 29, 3422–3435 (2021).
pubmed: 34371184 pmcid: 8636169 doi: 10.1016/j.ymthe.2021.08.005
Han, H. et al. N7-methylguanosine tRNA modification promotes esophageal squamous cell carcinoma tumorigenesis via the RPTOR/ULK1/autophagy axis. Nat. Commun. 13, 1478 (2022).
pubmed: 35304469 pmcid: 8933395 doi: 10.1038/s41467-022-29125-7
Chen, J. et al. Aberrant translation regulated by METTL1/WDR4‐mediated tRNA N7‐methylguanosine modification drives head and neck squamous cell carcinoma progression. Cancer Commun. 42, 223–244 (2022).
doi: 10.1002/cac2.12273
Shaheen, R. et al. Mutation in WDR4 impairs tRNA m
pubmed: 26416026 pmcid: 4587777 doi: 10.1186/s13059-015-0779-x
Braun, D. A. et al. Mutations in WDR4 as a new cause of Galloway–Mowat syndrome. Am. J. Med. Genet. A 176, 2460–2465 (2018).
pubmed: 30079490 pmcid: 6289609 doi: 10.1002/ajmg.a.40489
Trimouille, A. et al. Further delineation of the phenotype caused by biallelic variants in the WDR4 gene. Clin. Genet. 93, 374–377 (2018).
pubmed: 28617965 doi: 10.1111/cge.13074
Cartlidge, R. A. et al. The tRNA methylase METTL1 is phosphorylated and inactivated by PKB and RSK in vitro and in cells. EMBO J. 24, 1696–1705 (2005).
pubmed: 15861136 pmcid: 1142581 doi: 10.1038/sj.emboj.7600648
Torres, A. G., Batlle, E. & de Pouplana, L. R. Role of tRNA modifications in human diseases. Trends Mol. Med. 20, 306–314 (2014).
pubmed: 24581449 doi: 10.1016/j.molmed.2014.01.008
Suzuki, T. The expanding world of tRNA modifications and their disease relevance. Nat. Rev. Mol. Cell Biol. 22, 375–392 (2021).
pubmed: 33658722 doi: 10.1038/s41580-021-00342-0
Pan, T. Modifications and functional genomics of human transfer RNA. Cell Res. 28, 395–404 (2018).
pubmed: 29463900 pmcid: 5939049 doi: 10.1038/s41422-018-0013-y
Schimmel, P. The emerging complexity of the tRNA world: mammalian tRNAs beyond protein synthesis. Nat. Rev. Mol. Cell Biol. 19, 45–58 (2018).
pubmed: 28875994 doi: 10.1038/nrm.2017.77
Lin, S. et al. Mettl1/Wdr4-mediated m
pubmed: 29983320 pmcid: 6086580 doi: 10.1016/j.molcel.2018.06.001
Matsumoto, K. et al. RNA recognition mechanism of eukaryote tRNA (m7G46) methyltransferase (Trm8–Trm82 complex). FEBS Lett. 581, 1599–1604 (2007).
pubmed: 17382321 doi: 10.1016/j.febslet.2007.03.023
Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583–589 (2021).
pubmed: 34265844 pmcid: 8371605 doi: 10.1038/s41586-021-03819-2
Shi, H. & Moore, P. B. The crystal structure of yeast phenylalanine tRNA at 1.93 Å resolution: a classic structure revisited. RNA 6, 1091–1105 (2000).
pubmed: 10943889 pmcid: 1369984 doi: 10.1017/S1355838200000364
Blersch, K. F. et al. Structural model of the M7G46 methyltransferase TrmB in complex with tRNA. RNA Biol. 18, 2466–2479 (2021).
pubmed: 34006170 pmcid: 8632124 doi: 10.1080/15476286.2021.1925477
Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290–296 (2017).
pubmed: 28165473 doi: 10.1038/nmeth.4169
Yue, H. et al. Rapid ‘mix and read’ assay for scalable detection of SARS-CoV-2 antibodies in patient plasma. Preprint at medRxiv https://doi.org/10.1101/2020.09.01.20184101 (2020).
Kabsch, W. Xds. Acta Crystallogr. D Biol. Crystallogr. 66, 125–132 (2010).
pubmed: 20124692 pmcid: 2815665 doi: 10.1107/S0907444909047337
Liebschner, D. et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr. D Struct. Biol. 75, 861–877 (2019).
pubmed: 31588918 pmcid: 6778852 doi: 10.1107/S2059798319011471
Chen, V. B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D Biol. Crystallogr. 66, 12–21 (2010).
pubmed: 20057044 doi: 10.1107/S0907444909042073
Morin, A. et al. Cutting edge: collaboration gets the most out of software. eLife 2, e01456 (2013).
pubmed: 24040512 pmcid: 3771563 doi: 10.7554/eLife.01456
Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331–332 (2017).
pubmed: 28250466 pmcid: 5494038 doi: 10.1038/nmeth.4193
Bepler, T. et al. Positive-unlabeled convolutional neural networks for particle picking in cryo-electron micrographs. Nat. Methods 16, 1153–1160 (2019).
pubmed: 31591578 pmcid: 6858545 doi: 10.1038/s41592-019-0575-8
Zivanov, J., Nakane, T. & Scheres, S. H. A Bayesian approach to beam-induced motion correction in cryo-EM single-particle analysis. IUCrJ 6, 5–17 (2019).
pubmed: 30713699 pmcid: 6327179 doi: 10.1107/S205225251801463X
Punjani, A., Zhang, H. & Fleet, D. J. Non-uniform refinement: adaptive regularization improves single-particle cryo-EM reconstruction. Nat. Methods 17, 1214–1221 (2020).
pubmed: 33257830 doi: 10.1038/s41592-020-00990-8
Punjani, A. & Fleet, D. J. 3D variability analysis: resolving continuous flexibility and discrete heterogeneity from single particle cryo-EM. J. Struct. Biol. 213, 107702 (2021).
pubmed: 33582281 doi: 10.1016/j.jsb.2021.107702
Aiyer, S., Zhang, C., Baldwin, P. R. & Lyumkis, D. in CryoEM (eds. Gonen, T. & Nannenga, B. L.) 161–187 (Springer, 2021).
Sanchez-Garcia, R. et al. DeepEMhancer: a deep learning solution for cryo-EM volume post-processing. Commun. Biol. 4, 874 (2021).
pubmed: 34267316 pmcid: 8282847 doi: 10.1038/s42003-021-02399-1
Pettersen, E. F. et al. UCSF ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci. 30, 70–82 (2021).
pubmed: 32881101 doi: 10.1002/pro.3943
Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486–501 (2010).
pubmed: 20383002 pmcid: 2852313 doi: 10.1107/S0907444910007493
Delaglio, F. et al. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6, 277–293 (1995).
pubmed: 8520220 doi: 10.1007/BF00197809
Vranken, W. F. et al. The CCPN data model for NMR spectroscopy: development of a software pipeline. Proteins Struct. Funct. Bioinf. 59, 687–696 (2005).
doi: 10.1002/prot.20449
Hyberts, S. G., Takeuchi, K. & Wagner, G. Poisson-gap sampling and forward maximum entropy reconstruction for enhancing the resolution and sensitivity of protein NMR data. J. Am. Chem. Soc. 132, 2145–2147 (2010).
pubmed: 20121194 pmcid: 2825045 doi: 10.1021/ja908004w
Hyberts, S. G., Milbradt, A. G., Wagner, A. B., Arthanari, H. & Wagner, G. Application of iterative soft thresholding for fast reconstruction of NMR data non-uniformly sampled with multidimensional Poisson gap scheduling. J. Biomol. NMR 52, 315–327 (2012).
pubmed: 22331404 pmcid: 3321367 doi: 10.1007/s10858-012-9611-z
Shen, Y. & Bax, A. Protein backbone and sidechain torsion angles predicted from NMR chemical shifts using artificial neural networks. J. Biomol. NMR 56, 227–241 (2013).
pubmed: 23728592 pmcid: 3701756 doi: 10.1007/s10858-013-9741-y

Auteurs

Jiazhi Li (J)

Stem Cell Program, Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.

Longfei Wang (L)

Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA, USA.
School of Pharmaceutical Sciences, Wuhan University, Wuhan, China.

Quentin Hahn (Q)

Stem Cell Program, Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.

Radosław P Nowak (RP)

Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.

Thibault Viennet (T)

Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.

Esteban A Orellana (EA)

Stem Cell Program, Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.

Shourya S Roy Burman (SS)

Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.

Hong Yue (H)

Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.

Moritz Hunkeler (M)

Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.

Pietro Fontana (P)

Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA, USA.

Hao Wu (H)

Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA, USA.

Haribabu Arthanari (H)

Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.

Eric S Fischer (ES)

Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.

Richard I Gregory (RI)

Stem Cell Program, Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA. rgregory@enders.tch.harvard.edu.
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA. rgregory@enders.tch.harvard.edu.
Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA. rgregory@enders.tch.harvard.edu.
Department of Pediatrics, Harvard Medical School, Boston, MA, USA. rgregory@enders.tch.harvard.edu.
Harvard Stem Cell Institute, Cambridge, MA, USA. rgregory@enders.tch.harvard.edu.
Harvard Initiative for RNA Medicine, Boston, MA, USA. rgregory@enders.tch.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH